To induce a dMMR phenotype in neuroblastoma tumors, we knocked out the MLH1 gene in a poorly immunogenic syngeneic murine neuroblastoma cell line, neuro-2a, using the clustered regularly interspaced short palindromic repeats-associated protein (CRISPR-Cas9) technology. This evidence concerns the gene MLH1 and neuroblastoma.